Apyx Medical Corporation Common Stock (APYX) Stock Price

APYXStock

$2.55−18.01%52W

Market Cap$107.42M

P/E—

PEG Ratio0.59

Div yield—

Beta1.53

APYX Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-43.50%

Price vs S&P 500 (4W)-11.05%

PEG Ratio0.59

VGM Score48.71

Book Value / Share (Quarterly)$0.25

P/TBV (Annual)4.17x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)5.89%

Cash Flow / Share (Quarterly)$-0.26

Price vs S&P 500 (YTD)-39.07%

Gross Margin (TTM)63.50%

Net Profit Margin (TTM)-14.78%

EPS (TTM)$-0.20

10-Day Avg Trading Volume0.10M

EPS Excl Extra (TTM)$-0.20

Revenue Growth (5Y)13.78%

EPS (Annual)$-0.27

ROI (Annual)-22.68%

Gross Margin (Annual)62.53%

Net Profit Margin (5Y Avg)-37.82%

Cash / Share (Quarterly)$0.66

Revenue Growth QoQ (YoY)22.08%

ROA (Last FY)-16.77%

Revenue Growth TTM (YoY)25.59%

EBITD / Share (TTM)$-0.06

ROE (5Y Avg)-80.45%

Operating Margin (TTM)-6.06%

Cash Flow / Share (Annual)$-0.22

P/B Ratio10.07x

P/B Ratio (Quarterly)17.65x

Net Income / Employee (Annual)$-54,700

EV / Revenue (TTM)1.97x

Net Interest Coverage (TTM)-1.42x

ROA (TTM)-13.91%

EV / EBITDA (TTM)166.88x

EPS Incl Extra (Annual)$-0.27

Current Ratio (Annual)5.00x

Quick Ratio (Quarterly)4.41x

3-Month Avg Trading Volume0.13M

52-Week Price Return-18.01%

Revenue / Employee (TTM)$285,000

Tangible BV / Share (Quarterly)$2.38

P/S Ratio (Annual)2.03x

Asset Turnover (Annual)0.79x

52-Week High$5.08

Operating Margin (5Y Avg)-34.59%

EPS Excl Extra (Annual)$-0.27

CapEx CAGR (5Y)13.94%

Tangible BV CAGR (5Y)-0.37%

26-Week Price Return-33.59%

Quick Ratio (Annual)4.16x

13-Week Price Return-40.42%

Total Debt / Equity (Annual)2.40x

Current Ratio (Quarterly)5.68x

Enterprise Value$115.15M

Revenue / Share Growth (5Y)9.68%

Asset Turnover (TTM)0.94x

Book Value / Share Growth (5Y)-28.47%

Revenue / Employee (Annual)$257,800

Inventory Turnover (Annual)2.45x

Pretax Margin (Annual)-20.50%

Cash / Share (Annual)$0.76

3-Month Return Std Dev66.45%

Gross Margin (5Y Avg)64.55%

Net Income / Employee (TTM)$-42,100

ROE (Last FY)-77.10%

Net Interest Coverage (Annual)-0.75x

EPS Basic Excl Extra (Annual)$-0.27

P/FCF (TTM)30.52x

Receivables Turnover (TTM)4.70x

Total Debt / Equity (Quarterly)3.32x

EPS Incl Extra (TTM)$-0.20

Receivables Turnover (Annual)3.26x

ROI (TTM)-18.78%

P/S Ratio (TTM)1.84x

Pretax Margin (5Y Avg)-38.32%

Revenue / Share (Annual)$1.29

Tangible BV / Share (Annual)$0.62

Price vs S&P 500 (52W)-33.54%

Year-to-Date Return-27.14%

5-Day Price Return-3.77%

EPS Normalized (Annual)$-0.27

ROA (5Y Avg)-28.68%

Net Profit Margin (Annual)-21.22%

Month-to-Date Return4.08%

Cash Flow / Share (TTM)$-0.42

EBITD / Share (Annual)$-0.14

Operating Margin (Annual)-12.20%

LT Debt / Equity (Annual)2.40x

ROI (5Y Avg)-38.45%

LT Debt / Equity (Quarterly)3.31x

EPS Basic Excl Extra (TTM)$-0.20

P/TBV (Quarterly)2.92x

P/B Ratio (Annual)9.88x

Inventory Turnover (TTM)2.25x

Pretax Margin (TTM)-13.65%

Book Value / Share (Annual)$0.35

Price vs S&P 500 (13W)-43.11%

Beta1.53x

P/FCF (Annual)78.98x

Revenue / Share (TTM)$1.33

ROE (TTM)-78.70%

52-Week Low$2.32

vGradeC

gGradeB

mGradeD

vgmGradeC

APYX Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 6, 2026	-$0.08	-$0.07	+14.63%(+$0.01)
Q1 2026	May 7, 2026	-$0.11	-$0.05	+54.55%(+$0.06)
Q4 2025	Mar 10, 2026	-$0.06	-$0.03	+46.43%(+$0.03)
Q3 2025	Nov 6, 2025	-$0.10	-$0.05	+51.22%(+$0.05)
Q2 2025	Aug 7, 2025	-$0.09	-$0.09	+3.57%(+$0.00)

APYX Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

4.20

4.18

Industry Peers — Surgical & Medical Instruments(142)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth (5Y)	Gross Margin (TTM)	Operating Margin (TTM)	Price
APYXApyx Medical Corporation Common Stock	C	B	D	1.8x	13.8%	63.5%	-6.1%	$2.55
SYKStryker Corporation	C	B	C	4.4x	11.8%	65.3%	21.3%	$294.66
MMM3M Company	C	D	B	3.4x	-5.0%	39.4%	18.4%	$164.75
BSXBoston Scientific Corp.	C	B	C	3.1x	15.2%	69.5%	19.8%	$44.39
BDXBecton, Dickinson and Co.	B	D	A	2.5x	6.3%	46.7%	9.6%	$191.75
MDLNMedline Inc. Class A common stock	C	D	C	1.6x	—	26.2%	6.0%	$35.96
RMDResMed Inc.	C	C	B	5.9x	12.1%	61.1%	33.4%	$238.97
DXCMDexCom, Inc.	C	B	B	6.5x	19.3%	64.3%	22.9%	$86.04
WSTWest Pharmaceutical Services, Inc.	D	C	A	8.5x	7.4%	36.8%	20.4%	$384.02
SOLVSolventum Corporation	C	C	B	1.8x	—	54.8%	23.9%	$85.81
BAXBaxter International Inc.	B	D	B	1.1x	-0.8%	30.7%	-2.3%	$25.28
PENPenumbra, Inc.	F	C	B	8.4x	20.2%	67.8%	12.4%	$320.86
GMEDGLOBUS MEDICAL INC	B	B	B	3.3x	30.1%	68.5%	20.6%	$76.71
PODDInsulet Corporation	C	A	C	3.2x	24.5%	71.1%	16.9%	$141.10
GKOSGlaukos Corporation	F	A	B	15.9x	17.7%	79.1%	-31.6%	$164.84
TFXTeleflex Incorporated	B	F	B	2.1x	-4.7%	53.8%	-11.7%	$130.43
HAEHaemonetics Corporation	C	C	A	4.0x	8.9%	59.1%	11.9%	$118.28
MMSIMerit Medical Systems Inc	C	B	B	3.4x	9.5%	49.5%	12.8%	$89.20
STVNStevanato Group S.p.A.	D	C	C	3.7x	12.4%	29.9%	16.4%	$18.90
MMEDMiniMed Group, Inc. Common Stock	—	—	B	—	—	—	—	$17.49
HTFLHeartflow, Inc. Common Stock	F	A	A	19.8x	—	80.1%	-40.8%	$48.29
ICUIICU Medical Inc	C	D	B	1.9x	11.9%	39.1%	3.5%	$162.99
IRTCiRhythm Holdings, Inc. Common Stock	D	B	C	4.3x	23.0%	71.5%	-3.0%	$108.66
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	2725.9x	—	0.3%	-7007.8%	$44.43
ATRCAtriCure, Inc.	D	B	A	5.0x	20.9%	76.3%	2.3%	$56.07
UFPTUFP Technologies Inc	C	B	A	3.6x	27.4%	28.5%	15.3%	$291.67
INSPInspire Medical Systems, Inc.	B	B	B	2.2x	51.2%	86.1%	6.0%	$68.79
LMATLeMaitre Vascular, Inc.	C	B	C	7.0x	14.0%	72.9%	29.5%	$80.82
NVCRNovoCure Limited Ordinary Shares	D	C	C	2.3x	5.8%	76.1%	-22.1%	$14.07
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	15.2x	—	53.9%	-140.4%	$27.24
ATECAlphatec Holdings, Inc.	D	B	C	2.0x	39.5%	70.8%	-7.5%	$10.46
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	B	—	—	—	—	$12.29
TNDMTandem Diabetes Care, Inc.	D	C	C	1.1x	15.3%	56.0%	-4.4%	$16.24
IRMDiRadimed Corporation	D	B	B	13.1x	21.4%	75.9%	31.9%	$88.27
AORTArtivion, Inc.	C	C	C	2.3x	11.8%	64.4%	2.9%	$21.78
IARTIntegra LifeSciences Holdings	B	F	C	0.6x	3.6%	57.2%	4.0%	$13.21
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	3.0x	109.0%	64.2%	-33.9%	$17.57
BVSBioventus Inc. Class A Common Stock	B	C	A	1.9x	12.1%	68.7%	10.0%	$13.30
BBNXBeta Bionics, Inc. Common Stock	D	A	C	7.4x	—	58.3%	-69.8%	$16.35
SIBNSI-BONE, Inc. Common Stock	D	B	B	4.1x	22.3%	79.5%	-8.3%	$19.68
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	—	—	—	—	$24.00
MDXGMiMedx Group, Inc	C	D	C	1.8x	11.0%	78.8%	2.5%	$4.43
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	2.3x	27.2%	73.7%	-11.9%	$21.95
TCMDTactile Systems Technology, Inc.	B	B	B	1.5x	12.0%	51.9%	10.0%	$22.52
SSIISS Innovations International Inc. Common Stock	F	A	D	9.7x	—	47.6%	-16.2%	$2.53
DCTHDelcath Systems Inc	D	C	B	5.1x	120.1%	87.0%	-1.9%	$14.08
ANGOAngioDynamics, Inc.	C	D	C	1.5x	1.9%	55.6%	-11.2%	$11.24
BWAYBrainsway Ltd. American Depositary Shares	D	B	B	9.5x	12.2%	74.9%	5.8%	$11.44
SGHTSight Sciences, Inc. Common Stock	D	B	A	5.5x	22.9%	88.4%	-33.4%	$8.28
CERSCerus Corp	D	C	C	1.8x	15.4%	57.2%	-0.7%	$2.18
NPCENeuropace, Inc. Common Stock	D	C	C	4.3x	19.4%	79.6%	-15.3%	$12.24

About Apyx Medical Corporation Common Stock

Apyx Medical Corp manufactures energy-based medical devices for cosmetic and surgical markets. Its core products include Renuvion, a controlled heat technology used by plastic and cosmetic surgeons, and J-Plasma, a precision surgical system designed to minimize tissue damage. The company's Advanced Energy segment represents its primary revenue driver.

APYX Next Earnings Report

Report dateNov 5, 2026

QuarterQ3 2026

Report timeAMC

EPS estimate-$0.09

Revenue estimate$13.29M

Also reporting on Nov 5, 2026

Scheduled date with consensus estimates — both can change before the company reports.

Earnings calendar for November 2026

Companies in Related Industries

QTRXQuanterix Corporation Common StockLab Analytical Instruments
OWLTOwlet, Inc.Measuring & Controlling Devices
SEERSeer, Inc. Class A Common StockLab Analytical Instruments
CODACoda Octopus Group, Inc. Common stockDefense Systems & Equipment
STXSStereotaxis, Inc. Common StockElectromedical Equipment
VANIVivani Medical, Inc. Common Stock (DE)Electromedical Equipment
NRXSNeuraxis, Inc.Electromedical Equipment
KEQUKewaunee Scientific CorpLab Apparatus & Furniture

Same SIC sector, outside this company's own industry.

Analyst Sentiment

4.2

Buy

Consensus rating

52-Week Range

Low$2.32

High$5.08